Less than 100 children in the U.S. die each year from seasonal flu viruses.[iv] If we use Australia’s math, a very rough estimate would be another 100 children could potentially die of swine flu in the United States in the coming year.
If children are the first target group in the U.S. per Sebelius, that means we’re about to inject around 75 million children with a fast tracked vaccine containing novel adjuvants, including dangerous squalene, to prevent perhaps 100 deaths.
I’m not overlooking the tragedy of the loss of even one child to an illness like the H1N1 flu virus. But there can be no argument that unnecessary mass injection of millions of children with a vaccine containing an adjuvant known to cause a host of debilitating autoimmune diseases is a reckless, dangerous plan.
Flu vaccines can also contain a number of chemical toxins, including ethylene glycol (antifreeze), formaldehyde, phenol (carbolic acid) and even antibiotics like Neomycin and streptomycin.
Novartis’s proprietary squalene adjuvant for their H1N1 vaccine is MF59. Glaxo’s is ASO3. MF59 has yet to be approved by the FDA for use in any U.S. vaccine, despite its history of use in other countries.
Per Dr. Nass, there are only three vaccines in existence using an approved squalene adjuvant. None of the three are approved for use in the U.S.
Oil-based vaccination adjuvants like squalene have been proved to generate concentrated, unremitting immune responses over long periods of time.
A 2000 study published in the American Journal of Pathology demonstrated a single injection of the adjuvant squalene into rats triggered “chronic, immune-mediated joint-specific inflammation,” also known as rheumatoid arthritis.
Gulf War veterans with Gulf War Syndrome (GWS) received anthrax vaccines which contained squalene.[ix] MF59 (the Novartis squalene adjuvant) was an unapproved ingredient in experimental anthrax vaccines and has since been linked to the devastating autoimmune diseases suffered by countless Gulf War vets.[x]
The Department of Defense made every attempt to deny that squalene was indeed an added contaminant in the anthrax vaccine administered to Persian Gulf war military personnel – deployed and non-deployed – as well as participants in the more recent Anthrax Vaccine Immunization Program (AVIP).
. The military and federal health agencies have long kept their SQUALENE experiments on U.S. military troops secret because they know that oil-based adjuvants wreak havoc with immune function, causing the body to attack itself. Matsumoto documents how federal and military officials have often been caught lying about the SQUALENE in military vaccines.
Squalene is a natural organic compound originally obtained for commercial purposes primarily from shark liver oil, though botanic sources are used as well, including amaranth seed, rice bran, wheat germ, and olives. All higher organisms produce squalene, including humans. It is a hydrocarbon and a triterpene.
In vaccine development, squalene has been used as an adjuvant, which increases the immune response of vaccines that would otherwise be too weak to offer protection. A squalene adjuvant was used in a cytomegalovirus vaccine. Some animal studies have found adverse effects, such as weakness, from squalene, and some veterans have claimed that squalene adjuvant in vaccines was responsible for Gulf War Syndrome.
One of the other projects likely to be near the top of the two companies' target list is the development of an improved influenza vaccine.to induce the strongest immune response in humans.
Originally posted by pteridine
reply to post by marg6043
Squalene is a component of shark oil and has not been shown to be the cause of any adverse effects in vaccines. Water is the major ingredient, so you might want to indict water as the culprit.
squalene can be purchased at health food stores in its more commonly known form, “shark liver oil.” However, ingested squalene has a completely different effect on the body than injected squalene. When molecules of squalene enter the body through an injection, even at concentrations as small as 10 to 20 parts per billion, it can lead to self-destructive immune responses, such as autoimmune arthritis and lupus.
Rats made congenic for Oia3 on chromosome 10 become susceptible to squalene-induced arthritis.
Arthritis development was provoked in Oia3-congenic rats by intradermal injection of different adjuvant oils. One successful arthritis trigger was squalene, which is approved for vaccinations in humans and has been implicated in Gulf War syndrome.
We demonstrate that arthritis induced with the endogenous adjuvant squalene displays clinical similarities with previously described adjuvant-induced arthritides and RA. The disease is T cell dependent, influenced by both MHC and non-MHC genes and displays a chronic course in certain animals. Susceptibility to squalene-induced arthritis (SIA) is influenced by the quantitative trait loci (QTLs) Oia2 and Oia3, thereby displaying both clinical and genetic resemblances to OIA.
The Endogenous Adjuvant Squalene Can Induce a Chronic T-Cell-Mediated Arthritis in Rats
Barbro C. Carlson*, Åsa M. Jansson*, Anders Larsson, Anders Bucht* and Johnny C. Lorentzen*
From the Department of Medicine,*
Unit of Rheumatology, Karolinska Institutet, Stockholm; the Department of Medical Sciences,
University Hospital, Uppsala; and the Department of Biomedicine,
Division of NBC Defense, Defense Research Establishment, Umeå, Sweden
Squalene is a cholesterol precursor, which stimulates the immune system nonspecifically. We demonstrate that one intradermal injection of this adjuvant lipid can induce joint-specific inflammation in arthritis-prone DA rats. Histopathological and immunohistochemical analyses revealed erosion of bone and cartilage, and that development of polyarthritis coincided with infiltration of ß+ T cells.